相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise
Catharine H. Duman et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Escitalopram in the treatment of major depressive disorder: A meta-analysis
Sidney H. Kennedy et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Karl Rickels et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani et al.
LANCET (2009)
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Pathophysiology of depression: Role of sleep and the melatonergic system
Venkataramanujan Srinivasan et al.
PSYCHIATRY RESEARCH (2009)
A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression
Brendon Binneman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder
Shima Jazayeri et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2008)
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs
Charles B. Nemeroff et al.
BIOLOGICAL PSYCHIATRY (2008)
Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Shu-Feng Zhou et al.
CURRENT DRUG METABOLISM (2008)
Psychotropic prescription practices in east Asia: looking back and peering ahead
Chay-Hoon Tan et al.
CURRENT OPINION IN PSYCHIATRY (2008)
Central CRH system in depression and anxiety -: Evidence from clinical studies with CRH1 receptor antagonists
Florian Holsboer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects
M. E. Breuer et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder
Maria Eugenia Hernandez et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Circadian rhythm disturbances in depression
Anne Germain et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): A pooled analysis of 10 studies
George I. Papakostas et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Omega-3 fatty acids for major depressive disorder during pyegnancy: Results from a randomized, double-blind, placebo-controlled trial
Kuan-Pin Su et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder - Results of a double-blind, placebo-controlled trial
Karl Rickels et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR
Sidney H. Kennedy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder - A preliminary study
Tony P. George et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia
Peter Gallagher et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Cross-Talk between Dopaminergic and Noradrenergic Systems in the Rat Ventral Tegmental Area, Locus Ceruleus, and Dorsal Hippocampus
Bruno P. Guiard et al.
MOLECULAR PHARMACOLOGY (2008)
Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons
Alessia Bachis et al.
NEUROPHARMACOLOGY (2008)
Novel drugs and therapeutic targets for severe mood disorders
Sanjay J. Mathew et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent:: Relevance to its anti depressant/anxiolytic-like profile
Y. Claustre et al.
NEUROSCIENCE (2008)
Effects of sibutramine and orlistat on mood in obese and overweight subjects: A randomised study
D. N. Kiortsis et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis
Barbara Segal et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2008)
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial
I. Jon Russell et al.
PAIN (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models
Caroline Louis et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
New onset depression following myocardial infarction predicts cardiac mortality
Chris Dickens et al.
PSYCHOSOMATIC MEDICINE (2008)
Comorbid depression in rheumatoid arthritis: Pathophysiology and clinical implications
Travis O. Bruce
Current Psychiatry Reports (2008)
Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1
Kayoko Kawai et al.
JOURNAL OF BIOCHEMISTRY (2008)
Utilization, price, and spending trends for antidepressants in the US Medicaid program
Yan Chen et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2008)
Pharmacogenetic studies in depression: a proposal for methodologic guidelines
A. Serretti et al.
PHARMACOGENOMICS JOURNAL (2008)
Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks
R. Krishnan et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: Randomized, double-blind comparison with venlafaxine
Patrick Lemoine et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cγ signaling pathways in mouse brain
Tomi Rantamaki et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Better sexual acceptability of agomelatine compared to paroxetine in healthy male volunteers using the PRSexDQ Scale
A. L. Montejo et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial
Brin F. S. Grenyer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions
Seung-Won Park et al.
JOURNAL OF NEUROSURGERY (2007)
High-affinity CRF1 receptor antagonist NBI-34041:: Preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response
Marcus Ising et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs
Agnieszka Palucha et al.
PHARMACOLOGY & THERAPEUTICS (2007)
A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids
Pao-Yen Lin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories
S. A. Heldt et al.
MOLECULAR PSYCHIATRY (2007)
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
Robert M. Berman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: A meta-analysis
George I. Papakostas et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
An open-label, flexible-dose study of memantine in major depressive disorder
James M. Ferguson et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder
Jun-ichi Iga et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: A 4-week open-label parallel-group study
Cornelius Schuele et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2007)
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy
Sinead M. O'Brien et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
The role of dopamine in the pathophysiology of depression
Boadie W. Dunlop et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
George I. Papakostas et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2006)
Antidepressant efficacy of the antimuscarinic drug scopolamine - A randomized, placebo-controlled clinical trial
Maura L. Furey et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A neurotrophic model for stress-related mood disorders
Ronald S. Duman et al.
BIOLOGICAL PSYCHIATRY (2006)
Clinical and biological effects of mifepristone treatment for psychotic depression
BH Flores et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder
M Keller et al.
BIOLOGICAL PSYCHIATRY (2006)
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
SH Kennedy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
A double-blind, placebo-controlled study of memantine in the treatment of major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression
MP Freeman et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine
GI Papakostas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Antidepressant utilization in Canada
CA Beck et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2005)
Weight gain, sexual dysfunction, and bupropion
MJ Menaster
JOURNAL OF CLINICAL PSYCHIATRY (2005)
The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects
ND Volkow et al.
BIOLOGICAL PSYCHIATRY (2005)
Cytokines as a precipitant of depressive illness: Animal and human studies
H Anisman et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
JM O'Donnell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression
MS Kramer et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats
T Itoh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: A randomized, double-blind, placebo-controlled discontinuation study
SA Montgomery et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder
AH Young et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Which factors influence psychiatrists' selection of antidepressants?
M Zimmerman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
An open-label trial of riluzole in patients with treatment-resistant major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Depression and other mental health diagnoses increase mortality risk after ischernic stroke
LS Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Riluzole augmentation for treatment-resistant depression
G Sanacora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials
MJ Taylor et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Pramipexole in treatment-resistant depression: An extended follow-up
P Cassano et al.
DEPRESSION AND ANXIETY (2004)
The economic burden of depression in the United States: How did it change between 1990 and 2000?
PE Greenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment
L Capuron et al.
BIOLOGICAL PSYCHIATRY (2003)
Untreated depression and hippocampal volume loss
YI Sheline et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cost of lost productive work time among US workers with depression
WF Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression
LB Marangell et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Antidepressant-like actions of DOV 21,947: a triple reuptake inhibitor
P Skolnick et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Course of illness, hippocampal function, and hippocampal volume in major depression
GM MacQueen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
An open label trial of C-1073 (mifepristone) for psychotic major depression
JK Belanoff et al.
BIOLOGICAL PSYCHIATRY (2002)
Antidepressants and neuroplasticity
C D'Sa et al.
BIPOLAR DISORDERS (2002)
Nicotinic acetylcholine receptors as targets for antidepressants
RD Shytle et al.
MOLECULAR PSYCHIATRY (2002)
Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus
KA Maubach et al.
NEUROSCIENCE (2002)
Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents
G Griebel et al.
PSYCHOPHARMACOLOGY (2001)
A novel augmentation strategy for treating resistant major depression
RC Shelton et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment
M Fava et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death
RM Sapolsky
BIOLOGICAL PSYCHIATRY (2000)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:: the first 20 patients treated
AW Zobel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
IM Anderson
JOURNAL OF AFFECTIVE DISORDERS (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus
K Fujimaki et al.
NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
